Literature DB >> 3976511

Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.

B Escoubet, P Coumel, J M Poirier, P Maison-Blanche, P Jaillon, J F Leclercq, P Menasche, G Cheymol, A Piwnica, G Lagier.   

Abstract

In 65 patients a single oral dose of amiodarone (30 mg/kg) produced an antiarrhythmic effect on supraventricular or ventricular arrhythmias within 3 to 8 hours and lasted for 17 to 19 hours. On the second day a 15-mg/kg dose reproduced this effect within 3 to 9 hours. Plasma concentration of amiodarone increased to a maximum (2.2 +/- 1.7 mg/liter) mean +/- standard deviation) at 6 +/- 3.5 hours and plasma levels of N-desethylamiodarone (NDA) rose to 0.2 +/- 0.08 mg/liter at 12 +/- 6.4 hours. Sixty-one other patients were given a single 30-mg/kg dose 7 hours to 4 days before open heart surgery. Biopsies of the right atrial and left ventricular walls were taken during surgery. Myocardial concentration of amiodarone was maximal in the atrium after 7 hours (13 +/- 8 mg/kg) and in the ventricle after 24 hours (17 +/- 11 mg/kg). NDA myocardial concentration increased progressively until 24 hours and then remained stable over 4 days (1.5 mg/kg). The amiodarone myocardial to plasma concentration ratio was similar in the atrium and in the ventricle and averaged 22 and 10 for amiodarone and NDA, respectively. A significant relation existed between amiodarone concentration and the effect on ventricular premature complexes (r = 0.74, p less than 0.001) and between amiodarone plasma concentration and the effect on the atrioventricular conduction (r = 0.58, p less than 0.001). The plasma concentration of amiodarone corresponding to a 60% decrease in arrhythmias averaged 1.5 to 2 mg/liter.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976511     DOI: 10.1016/0002-9149(85)90139-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Recent advances in understanding the pharmacology of amiodarone.

Authors:  S Nattel; M Talajic
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

2.  Comparison of the Length of Hospital Stay between the Patients with Atrial Fibrillation Treated with Amiodarone and Patients with Normal Sinus Rhythm after Coronary Artery Bypass Graft.

Authors:  Samad Shams Vahdati; Jahanbakhsh Samadikhah; Seied Hadi Hakim; Rasoul Azarfarin; Mahsa Ansarin
Journal:  J Cardiovasc Thorac Res       Date:  2012-02-17

3.  Comparison of acute electrophysiological effects of amiodarone and its metabolite desethylamiodarone in Langendorff perfused guinea pig hearts.

Authors:  G Stark; U Stark; M Windisch; M Vicenzi; U Eggenreich; S Nagl; K Kral; E Pilger; H A Tritthart
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

Review 4.  Practical aspects of the use of amiodarone.

Authors:  P Puech
Journal:  Drugs       Date:  1991       Impact factor: 9.546

5.  Flecainide acetate dose-concentration relationship in cardiac arrhythmias: influence of heart failure and amiodarone.

Authors:  J F Leclercq; I Denjoy; F Mentré; P Coumel
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 6.  Amiodaron in atrial fibrillation: post coronary artery bypass graft.

Authors:  Paria Habibollahi; Shahrzad Hashemi Jam; Samad Shams Vahdati; Hamidreza Morteza Baghi; Hassan Amiri
Journal:  World J Emerg Med       Date:  2016

7.  Amiodarone pharmacokinetics in coronary patients: differences between acute and one-month chronic dosing.

Authors:  J M Poirier; B Escoubet; P Jaillon; P Coumel; M O Richard; G Cheymol
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.